Minot Capital’s iShares Biotechnology ETF IBB Stock Holding History

Minot Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$897K	Hold	6,158	–	–	0.25%	6
2024 Q2	$845K	Hold	6,158	–	–	0.25%	12
2024 Q1	$845K	Hold	6,158	–	–	0.15%	12
2023 Q4	$837K	Hold	6,158	–	–	0.15%	12
2023 Q3	$753K	Hold	6,158	–	–	0.15%	12
2023 Q2	$782K	Sell	6,158 -5,611	-48%	-$729K	0.14%	19
2023 Q1	$1.52M	Hold	11,769	–	–	0.28%	19
2022 Q4	$1.55M	Hold	11,769	–	–	0.31%	19
2022 Q3	$1.4M	Hold	11,769	–	–	0.38%	18
2022 Q2	$1.38M	Buy	11,769 +6,158	+110%	+$731K	0.28%	18
2022 Q1	$731K	Hold	5,611	–	–	0.12%	18
2021 Q4	$856K	Buy	+5,611	New	+$869K	0.14%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Minot Capital's IBB Position: Q3 2024 in Review

Minot Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2024 at 6,158 shares worth $897K. The position accounts for 0.25% of the portfolio, ranked #6.

Minot Capital first reported a position in IBB in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.55M in Q4 2022. 895 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Minot Capital held 6,158 shares of iShares Biotechnology ETF worth $897K as of Q3 2024.
Minot Capital left its iShares Biotechnology ETF share count unchanged in Q3 2024.
iShares Biotechnology ETF made up 0.25% of Minot Capital's portfolio in Q3 2024, its #6 holding.
Minot Capital first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 12 quarters since.
Minot Capital's iShares Biotechnology ETF position peaked at $1.55M in Q4 2022.
895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Minot Capital's 13F filing for Q3 2024, filed 13 Nov 2024.